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Abstract 
Background: Diabetes mellitus (DM) is a chronic disease of the carbohydrate metabolism that, when not rigorously 
controlled, compromises systemic and organ integrity, thereby causing renal diseases, blindness, neuropathy, ar-
teriosclerosis, infections, and glandular dysfunction, including the salivary glands. The aim of this study was to 
determine the relationship between the qualitative and quantitative parameters of salivary alteration, which are 
indicators of salivary gland dysfunction, and the level of metabolic control of type 2 diabetes patients. 
Material and Methods: A convenience sample of 74 voluntary patients with type 2 DM was selected, each of whom 
donated a sample of unstimulated saliva.  Salivary parameters such as salivary flow rate, protein concentration, pH, 
and xerostomia were studied. 
Results: There is a positive relationship between the level of metabolic control measured with HbA1 and the pro-
tein concentration in saliva (Spearman rho = 0.329 and p = 0.004). The same assay showed an inverse correlation 
between HbA1 and pH (Spearman rho = -0.225 and p = 0.05). 
Conclusions: The protein concentration in saliva and, to a lesser extent, the pH may be useful as glandular dys-
function indicators in DM2 patients.
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Introduction
Diabetes mellitus (DM) is a chronic disease of carbo-
hydrate metabolism and, in its full expression, presents 
with hyperglycaemia, glycosuria, protein catabolism, 
ketosis, and acidosis (1). DM is caused by a decrease or 
absence of insulin secretion or of its biological activity 
and is associated with specific secondary lesions of the 
microcirculation as well as with neuropathic diseases 
and a predisposition to develop arteriosclerosis (2). Type 
1 diabetes (DM1) is an autoimmune disease that causes 
β cell destruction. Type 2 (DM2), however, affects a hig-
her percentage of diabetic patients. DM2 is influenced 
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by factors such as lifestyle, age, pregnancy, and obesity 
in addition to a strong genetic component. Eventually, 
systemic and organ integrity are compromised, causing 
renal diseases, arteriosclerosis, blindness, neuropathy, 
infections such as candidiasis, and dysfunction of diffe-
rent glands, including the salivary glands (3). 
DM2 requires rigorous self-control from the patient. 
When such rigor is not achieved, complications linked to 
the progression of the disease may occur that determine 
the aggravation of the prognosis and of the quality of life 
of the patient. The metabolic control of the disease is mo-
nitored using the glycated haemoglobin test (HbA1c) (4). 
This test measures the percentage of haemoglobin atta-
ched to glucose in a 90-day period. Levels of HbA1 < 7% 
are considered compatible with good metabolic control of 
the disease, while levels > 7% correspond to patients with 
poor metabolic control and with a higher risk of develo-
ping the complications described above (5).
The involvement of the parenchyma of the salivary 
glands of DM2 patients with modification in its perfor-
mance and its salivary production and composition has 
been described (6,7). Saliva has physical-chemical and 
biological properties that protect the tissues in the oral 
cavity. Saliva plays helps enable oral physiological pro-
cesses, such as phonation, mastication, digestion, and 
food tasting. Considering these aspects, a decrease in 
salivary production or changes in its qualitative proper-
ties may cause a health-related poor quality of life and 
represent a risk condition to develop oral pathologies 
such as caries, periodontal disease, angular cheilitis, and 
candidiasis (8-10).
Salivary gland damage in DM2 patients can cause quali-
tative and quantitative changes in the saliva. Xerostomia 
(dry mouth sensation) is also more frequent in these pa-
tients than in non-diabetic patients. 
Among the altered salivary parameters described in 
DM2 patients is the salivary flow rate (SFR), the pH, 
the salivary protein concentration and the xerostomia. 
Any of these parameters, singly or jointly, may reflect 
salivary gland damage (11).  
It is of great interest to identify the changes in the sali-
vary parameters that suggest glandular deterioration in 
DM2 patients according to the level of metabolic con-
trol of the disease, as adequate maintenance of the blood 
HbA1 levels may be more important in preventing tissue 
damage than the disease itself. 
To our knowledge, there is inadequate evidence on the as-
sociation of salivary parameters with the levels of the HbA1 
test in the same patient, but such information would help 
to determine the susceptibility to presenting oral diseases 
linked to these parameters and aid in both evaluating glan-
dular damage and improving the therapeutic approach. 
The aim of this study is to determine the possible as-
sociation between the alterations of the qualitative and 
quantitative salivary parameters that indicate glandular 
dysfunction and the metabolic control levels in patients 
with type 2 diabetes mellitus.
Material and Methods 
-Sample
A convenience sample of 74 voluntary subjects was 
selected from the Chilean Association of Diabetics 
(ADICH, for its acronym in Spanish). The selection 
was based on a non-probabilistic intentional method or 
done by convenience sampling, given the essential re-
search requirements (inclusion and exclusion criteria) 
with which the units of analysis had to comply. This 
study was performed on the premises of the ADICH, fo-
llowing the universal bioethics principles expressed by 
the Helsinki Declaration (12). Each subject had to sign a 
form indicating informed consent, previously approved 
by the Ethics Committee of the Faculty of Dentistry of 
the University of Chile. 
-Selection Criteria 
•Inclusion
Subjects of either sex over 30 years of age with a con-
firmed diagnosis of type 2 diabetes by the ADICH fo-
llowing the established criteria of the Ministry of Health 
(MINSAL, for its acronym in Spanish) (1). 
•Exclusion
Subjects with rheumatologic conditions, with previous 
head and neck radiotherapy, terminal diseases with neu-
rological damage, acute inflammatory oral conditions, 
or pregnancy were excluded from this study. 
-Determination of unstimulated salivary flow rate 
(SFR)
All saliva samples were taken by a single dental surgeon. 
Following a distilled water mouthwash and 5 minutes un-
der relaxed conditions (13) and deposit saliva for 5 minutes 
in a previously labelled sterile tube as described by Nava-
zesh et al. (14). The tube was later weighed by gravimetry, 
assigning a specific weight of 1.005 g/ml to the fluid, and 
the calculated total volume was expressed in ml/min.
-Saliva pH measurement 
The pH of the saliva samples from each individual was 
determined using saliva from the same tube for which 
the SFR was measured. A digital pH meter (PL-600 
EZDO-OMEGA model following the ISO-9001 regula-
tion) automatically provided the pH value digitally to 2 
decimal places (15). 
-Xerostomia evaluation
To evaluate the dry mouth sensation, the validated Fox 
test was applied (16) that consist in evaluate the patient’s 
subjective complaints that may include oral dryness, 
difficulty swallowing, problems speaking without addi-
tional liquid, burning sensation in the mouth, sensitivity 
to acidic or spicy foods and taste changes.
-Protein concentration in saliva
Kit BioRad protein assay (BRL SD 500-0002, Rich-
mond CA, USA) and standards bovine albumin (BSA, 
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Sigma) were used. Saliva samples analyzed were pro-
cessed in duplicate, in serial dilutions of 1: 100 to 1: 
200 and absorbance at 595 nm was determined. With the 
data obtained, a calibration curve was plotted and the 
concentration of total protein in mg / mL was estimated. 
A one-dimensional electrophoretic analysis. Aliquots of 
whole saliva containing equal amount of proteins were 
subjected to separation on SDS-polyacrylamide (10%) 
under reducing conditions according to the method des-
cribed by Laemmli et al. (17) and developed by staining 
with Coomassie Blue. Polypeptide bands that will be 
stained with purple dye were identified. The molecular 
weight was determined apparent of these bands, defined 
against calibration standard protein gels (Precision Plus 
Protein Standards, Dual Color, Bio Rad Catalog # 161-
0374). The unit of measurement of the concentration of 
proteins in saliva was ug / mL.
-HbA1c
HbA1c blood was used as the gold standard. This test 
is performed routinely in the ADICH to establish meta-
bolic control of the disease using the Variant II Bio Rad 
brand equipment, certified to the National Glycohemog-
lobin Standardization Program of the United States (18). 
The percentage describing the methodology, is obtained 
by affinity chromatography calculates the total and he-
moglobin HbA1c indirectly through a linear regression 
equation and the immunoassay, which specifically deter-
mines the percentage of HbA1c by reacting monoclonal 
antibodies. It was considered according to the protocol 
described by the committee of diagnosis and classifi-
cation of diabetes mellitus (19), a higher percentage of 
HbA1c to 7%, metabolic descompensation, while values 
below this percentage, compensation was considered 
metabolically.
-Statistical Analysis
A descriptive statistical analysis was performed based 
on the average and standard deviation for SFR, pH, and 
protein concentration. Normality for the quantitative 
variables was evaluated based on the Shapiro-Wilk test. 
For the quantitative variables, the values were calculated 
HbA1 < 7% (n=26) HbA1 > 7% (n=48) P
SFR (ml/min) 0.639 (SD 0.41) 0.518 (SD 0.31) N.S
pH 7.697 (SD 0.60) 7.552 (SD 0.60) 0.000
Protein concentration (µg/ml) 31.81 (SD 7.01) 36.60 (SD 6.71) 0.000
Xerostomia (n/%) 14 (53%) 13(50%) N.S
Table 1. Comparison of salivary parameters for DM2 patients with HbA1 levels over and under 7%.
Significant differences for pH and protein concentration were observed.
for a 95% confidence interval. Student’s t-test was used 
to compare the measurements between patients with DM 
2 and HbA1 > 7% and patients with DM2 and HbA1 
< 7%. To establish correlations between HbA1 and the 
variables SFR, pH and protein concentration, the Spear-
man correlation coefficient was used. Statistical diffe-
rences with a level of significance under 0.05 (p < 0.05) 
were accepted. The Stata 1.1 software was used to per-
form the statistical analysis.
Results
Of the subjects, 53 were women (71.6%) and 21 men 
(28.4%). The mean age for the total sample was 62.13 
(SD 10.13) years, 63.3 (SD 9.23) years for men and 59.3 
(SD 11.7) years for women. Twenty-six subjects had le-
vels of HbA1 under 7%, while 48 subjects had levels of 
HbA1 over 7%. An average of HbA1 level of 8.63 (SD 
2.27) was determined for the total sample. The minimum 
value was 5.7%, and the maximum was 13.7%. 
Table 1 shows the disaggregated values for the salivary 
parameter according to the metabolic control of DM2 
(HbA1 < 7% and HbA1 > 7%).
The average SFR value for the total group was 0.561 
(SD 0.354) ml/min. 
The average of the saliva pH values for the total group 
was 7.60 (SD 0.604). Significant differences were found 
between the two groups (t-test p = 0.000).
The average protein concentration in saliva for the to-
tal group was 34.92 (SD 7.152). Significant differences 
were found between the two groups (t-test p=0.000).
Of the patients with DM2 and HbA1 < 7%, 14 (53%) 
referred xerostomia, while 13 (50%) of the patients with 
DM2 and HbA1 > 7% referred this symptom. 
As shown in figure 1, the Spearman correlation coeffi-
cient showed a positive association between the level of 
metabolic control measured by HbA1 and the protein 
concentration (Spearman rho = 0.329 and p = 0.004). 
The same test also showed an inverse correlation bet-
ween HbA1 and pH (Spearman rho = -0.225 and p = 
0.05). SFR and HbA1 showed no association. 
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Fig. 1. Association between protein concentration in saliva and the 
levels of glycated haemoglobin (HbA1c). The levels of protein con-
centration in saliva were determined using spectrophotometry. Posi-
tive association between the two variables is observed.
Discussion
The aim of this study was to evaluate salivary gland dys-
function in patients with DM2, measuring the different 
levels of metabolic control with the HbA1 test and exa-
mining the SFR, pH, protein concentration and xerosto-
mia parameters. 
Although the DM2 patients with HbA1 > 7% showed a 
lower salivary flow than the DM2 patients with HbA1 
< 7%, this difference was not statistically significant 
when comparing the two groups. A correlation between 
the SFR and HbA1 variables was not observed, which 
would suggest a lower salivary flow linked to the wor-
sening of the metabolic control of DM2. While there 
is scarce evidence to link the SFR with HbA1, several 
studies suggest that patients with diabetes mellitus un-
dergo glandular damage that may translate into a lower 
salivary flow than in healthy subjects. Some authors (4, 
11) consider that this decrease is related to an increased 
diuresis or polyuria, involving a decrease in extracellu-
lar fluid and consequently in saliva production. Other 
authors explain this as a consequence of dehydration 
from glycosuria that would be more evident in cases 
of metabolic decompensation (7). However, this result 
was not observed in our study. Furthermore, according 
to our results, independently of the metabolic control of 
the disease, the salivary flow levels of DM2 patients are 
above the hyposalivation range (SFR < 0.2 ml/min), a 
risk category for the onset and progression of oral cavity 
diseases such as periodontitis and caries  (9,10).  
Our study found a higher protein concentration in saliva 
for DM2 patients with HbA1 > 7% compared to DM2 
patients with HbA1 < 7%. In addition, a positive asso-
ciation was observed between the degree of metabolic 
decompensation and the protein concentration in saliva 
(Spearman rho = 0.329 and p = 0.004). The increase in 
protein concentration in saliva is probably due to the 
reduced salivary fluid secretion described in diabetics 
(20). Another explanation for an increased presence of 
saliva proteins in DM2 subjects would be oral inflamma-
tory conditions such as periodontitis (21). In this case, 
the origin of the proteins in the total saliva composition 
would be mainly from the crevicular fluid. Although the 
periodontal health status was not evaluated in our study, 
it is possible that an increase in the severity of perio-
dontitis in decompensated DM2 patients might influence 
the protein composition parameter, as described in the 
literature (9,10,21). Although there are several explana-
tions for the higher protein concentration phenomenon 
in saliva in DM2 subjects, we suggest that more infor-
mation on its origin, characterisation, and individualised 
information is required. 
A lower pH in subjects with diabetes than in healthy sub-
jects has been reported in the literature (4). However, 
there is insufficient evidence correlating saliva pH with 
HbA1 values, as performed in our study. According to 
our results, there was a low but inverse correlation bet-
ween the variables (Spearman’s rho = -0.225 and p = 
0.05). That is, the pH becomes more acidic as the diabe-
tic decompensation increases. These changes in pH have 
been attributed in some studies to the decrease in bicar-
bonate in diabetic patients (22), which could be more 
evident as the disease progresses. Although a drop in the 
pH may be a risk factor for oral cavity disease such as 
periodontitis or caries (23), the values detected in the 
participants of our study, independent of the degree of 
metabolic control, continue to be considered normal or 
neutral and of low risk in relation to the etiopathogenesis 
of these oral pathologies. 
Regarding xerostomia, diabetic patients are more sub-
ject to present this condition than the non-diabetic po-
pulation, as described in the literature (24,25). There 
is insufficient evidence to associate this symptom with 
HbA1. In our study, the differences between patients 
with good and poor metabolic control of DM2 and the 
presentation of xerostomia were not observed. We also 
found no correlation between xerostomia and the mea-
sured parameters (SFR, pH and protein concentration in 
saliva). Furthermore, although 58% of our sample had 
hypertension and were under drug treatments that have 
been associated with dry mouth sensation (26), we did not 
observe an association with xerostomia (data not shown). 
Thus, we suggest that although a dry mouth sensation 
may be associated with diabetes, it is not a valid indicator 
of glandular dysfunction. Other salivary qualitative para-
meters were not analysed in this study, and thus we sug-
gest, in accordance with literature, that xerostomia could 
be a result of multiple factors, including the psychological 
status of patients with this condition (27).  
Our results show for the first time that decompensation, 
as measured by HbA1, may be linked to altered salivary 
parameters. According to our study, the protein con-
centration in saliva and, to a lesser extent, the pH may 
be useful as glandular dysfunction indicators in DM2 
patients. However, for this purpose, we believe that 
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broadening our sample would make our results more re-
liable but also that complementing our results with other 
studies including different salivary parameters would, 
jointly or individually, be useful in monitoring DM2 by 
offering a less invasive and lower cost alternative for the 
metabolic control of type 2 diabetes mellitus. 
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